Bezuclastinib
- Generic Name
- Bezuclastinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H17N5O
- CAS Number
- 1616385-51-3
- Unique Ingredient Identifier
- 2ROQ545LAG
- Associated Conditions
- -
- Associated Therapies
- -
(Apex) Bezuclastinib in Patients with Advanced Systemic Mastocytosis
- First Posted Date
- 2021-08-09
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Cogent Biosciences, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT04996875
- Locations
- 🇩🇪
UKSH Campus Lubeck, Lubeck, Germany
🇵🇱Public University Hospital No. 1 in Lublin, Lublin, Poland
🇺🇸University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath